Live Chat ×
Skip to main content

Genetic Mutations in MDS and AML and Its Impact on Treatment

Dr. Valeria Santini (recorded Dec. 2017) explains the implications of genetic mutations for the clinical management of myeloid neoplasms.

Recorded at the 2017 AAMDSIF/Cleveland Clinic Satellite Symposium Preceding the American Society of Hematology Annual Meeting.

Symposium Title: A Brave New World – The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy